IRIS - Res&Arch Institutional Research Information System - Research & Archive

VELARDI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.000
EU - Europa 3.429
AS - Asia 1.079
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 4
SA - Sud America 2
OC - Oceania 1
Totale 8.520
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.992
IE - Irlanda 780
IT - Italia 655
UA - Ucraina 614
SE - Svezia 573
HK - Hong Kong 315
SG - Singapore 278
CN - Cina 215
FI - Finlandia 193
VN - Vietnam 178
DE - Germania 155
RU - Federazione Russa 146
GB - Regno Unito 99
CH - Svizzera 38
FR - Francia 37
KR - Corea 35
TR - Turchia 29
BE - Belgio 28
CZ - Repubblica Ceca 25
RO - Romania 20
AT - Austria 19
GR - Grecia 15
NL - Olanda 14
UZ - Uzbekistan 13
PL - Polonia 11
LB - Libano 7
CA - Canada 5
EU - Europa 4
BG - Bulgaria 3
IN - India 3
MX - Messico 3
CI - Costa d'Avorio 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BN - Brunei Darussalam 1
BR - Brasile 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
HR - Croazia 1
JO - Giordania 1
JP - Giappone 1
MK - Macedonia 1
PE - Perù 1
SA - Arabia Saudita 1
SC - Seychelles 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 8.520
Salva come PNG Salva come JPEG
Città #
Dublin 780
Chandler 741
San Mateo 604
Jacksonville 323
Boardman 320
Hong Kong 313
Perugia 263
Singapore 187
Dong Ket 178
Medford 176
Princeton 175
Altamura 168
Ann Arbor 147
Wilmington 136
Lawrence 127
Andover 120
Beijing 89
Saint Petersburg 49
Des Moines 48
Norwalk 47
Helsinki 46
Ashburn 37
Shanghai 33
Woodbridge 32
Seoul 30
San Paolo di Civitate 26
Izmir 25
Redmond 25
Brussels 23
Los Angeles 22
New York 22
Brno 19
Falls Church 19
Rome 19
Bucharest 18
Dearborn 16
Houston 16
Santa Clara 16
Dallas 14
Auburn Hills 13
Foligno 13
Munich 13
Redwood City 12
Moscow 11
Prata Di Pordenone 11
Milan 10
Den Haag 8
Florence 8
Vienna 8
West Jordan 8
Padova 7
Renton 6
Ancona 5
Lappeenranta 5
Lausanne 5
Marsciano 5
Zaventem 5
Amsterdam 4
Bologna 4
Chicago 4
Deruta 4
Gubbio 4
Hanover 4
Hefei 4
Kocaeli 4
Philadelphia 4
Terni 4
Aurora 3
Guangzhou 3
Mirano 3
Monsheim 3
Nanning 3
Nuremberg 3
Ottawa 3
San Diego 3
Vigodarzere 3
Abidjan 2
Aigaleo 2
Bupyeong-gu 2
Castelfranco Emilia 2
Eunpyeong-gu 2
Falkenstein 2
Frankfurt Am Main 2
Fremont 2
Groningen 2
Hangzhou 2
Kunming 2
Ludwigshafen 2
Manchester 2
Monmouth Junction 2
Naples 2
Oklahoma City 2
Olomouc 2
Phoenix 2
Rho 2
San Mango 2
Santarcangelo di Romagna 2
Simi Valley 2
Stockholm 2
Venice 2
Totale 5.717
Salva come PNG Salva come JPEG
Nome #
Advances in full-haplotype mismatched transplants in acute leukemia 125
Innate immunity against hematological malignancies 100
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells 96
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. 88
14th International HLA and Immunogenetics Workshop: Report on hematopoietic cell transplantation. 88
Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation 86
T helper 2 antagonists restore antifungal T helper immunity in mice with T cell-depleted bone marrow transplantation 85
Comparison of immunosuppressive effects of single-dose and hyperfractionated total body irradiation 80
Fourth international workshop on haploidentical transplants, Naples, Italy 79
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 79
Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk 77
Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation. 74
Increased Ratio of CD31+/CD42- Microparticles to Endothelial Progenitors as a Novel Marker of Atherosclerosis in Hypercholesterolemia. 74
. G-CSF blocks IL-12 productin by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation. 73
New perspectives in haematopoietic stem cell transplantation. Transplantation across HLA barriers. 72
G-CSF blocks IL-12 production by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation.. 72
Haploidentical stem cell transplantation for acute leukemia 71
Non-MHC-restricted cytotoxic cells: Their roles in the control and treatment of leukaemias 70
Transplants across human leukocyte antigen barriers 70
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia 70
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 70
Natural killer cells: biology and application in stem-cell transplantation 69
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. 69
Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors 68
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. 68
The effect of TNF-α on regulatory T cell function in graft-versus-host disease 68
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 67
Haploidentical transplantation and natural killer cell recognition of missing self. 66
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 66
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 66
Noncanonical Fungal Autophagy Inhibits Inflammation in Response to IFN-γ via DAPK1. 66
The cross-talk between opportunistic fungi and the mammalian host via microbiota's metabolism 65
Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients 64
The role of megadose CD34+ progenitor cells in the treatment of leukemia patients without a matched donor and in tolerance induction for organ transplantation. . 63
null 63
Full-haplotype mismatched HSCT for high risk acute myeloid leukemia (AML). 63
16th IHIW: international histocompatibility working group in hematopoietic cell transplantation. 62
How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation 62
TNFR2 signaling modulates immunity after allogeneic hematopoietic cell transplantation 62
Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT. 61
Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation. 60
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 60
Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting 60
Natural killer cell alloreactivity for leukemia therapy. 60
Hematopoietic stem cell transplantation (HSCT) from alternative donors for acute leukemia at high-risk of relapse. the haploidentical option. 59
Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants 59
Total Marrow/Total Lymphoid Irradiation as Conditioning for Haploidentical Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients 59
Cellular therapy: exploiting NK cell alloreactivity in transplantation 58
Defective antifungal T-helper 1 (TH1) immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists. 58
Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation. 57
Allogeneic transplantation across the HLA barriers. 57
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 57
Clinical impact of natural killer cell reconstitution after allogenic hematopoitic transplantation.Immunobiology working Party of the European Group for Blood and Marrow Transplantation 57
Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation 56
Involvement of Cd44 Variant Isoforms In Hyaluronate Adhesion By Human Activated T-cells 56
A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation 56
"Designed" grafts for HLA-haploidentical stem cell transplantation. 55
Donor activating KIR genes and control of infections after haploidentical haematopoietic transplantation 55
Mismatched hematopoietic stem cell transplantation in secondary leukemia 54
Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. 54
The Total Body Irradiation Schedule Affects Acute Leukemia Relapse After Matched T Cell–Depleted Hematopoietic Stem Cell Transplantation 54
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 54
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 54
Genetic polymorphisms affecting IDO1 or IDO2 activity differently associate with aspergillosis in humans 54
Full haplotype mismatched transplant in high risk acute leukemia patients. 53
Allogenic and autologous transplantation for haematological diseases, solid tumours and immune disorders:current practice in europe 2009. 53
Natural killer cell-mediated lysis of autologous cells modified by gene therapy 52
CMV management with specific immunoglobulins: A multicentric retrospective analysis on 92 allotransplanted patients 52
CD4+FOXP3+ Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation 52
TLR3 essentially promotes protective class I-restricted memory CD8+ T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. 52
CD44 signaling through p56lck involves lateral association with CD4 in human CD4+ T cells. 51
Towards the identification of a tolerogenic signature in IDO-competent dendritic cells 51
Preclinical characterization of 1-7F9,a novel human anti-KIR receptor therapeutic antibody that augments natural kille-mediated killing of tumor cells. 51
Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translation. 51
T cell depletion and no post transplant immune suppression allow separation of graft versus leukemia from graft versus host disease 51
Stem cell transplantation from full-haplotype mismatched donors in leukemia . 50
Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell Transplantation 50
CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig. 49
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 49
New mechanism of lymphoma-induced bone marrow aplasia 49
. Mismatched hematopoietic stem cell transplants in elderly patients. 49
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. 48
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO) 48
Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation. 47
Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1. 47
NCRs and DNAM-1 mediate NK cell recognition and iysis of human and mouse melanoma cell lines in vitro and in vivo 47
Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance. 47
Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia 47
T cells expressing chimeric antigen receptor promote immune tolerance 47
Homozygosity for human leucocyte antigen-C ligands of KIR2DL1 is associated with increased risk of relapse after human leucocyte antigen-C-matched unrelated donor haematopoietic stem cell transplantation. 47
Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. 46
null 46
Natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation 46
Expansion of CD56-negative, CD16-positive, KIR-expressing natural killer cells after T cell-depleted haploidentical hematopoietic stem cell transplantation. 46
Deploying natural killer cell allotherapy in the setting of HLA-haplotype-mismatched hematopoietic stem cell transplantation 46
Natural killer cell allorecognition of missing self in allogenic hematopoietic transplantation :a tool for immunotherapy of leukemia. 45
Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors compared with HLA-identical siblings? 45
Foxp3+regulatory T cells maintain the bone marrow microenvironment for B cell lymphopoiesis 45
Trapianto di cellule staminali emopoietiche da donatore familiare HLA aploidentico incompatibile per tre loci. 44
Transplantation for high-risk acute leukemia with high doses of T cell-depleted hematopoietic stem cells from haploidentical “three loci” incompatible donors. 44
Totale 6.043
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.613
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.613
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020559 0 0 0 12 87 13 109 11 128 91 26 82
2020/20211.431 13 91 57 96 424 93 100 8 155 59 132 203
2021/20221.820 34 486 63 120 77 13 24 491 9 53 230 220
2022/20232.554 193 498 21 188 177 257 5 115 957 22 94 27
2023/20241.134 58 121 46 20 7 19 242 21 120 31 200 249
2024/2025419 59 271 88 1 0 0 0 0 0 0 0 0
Totale 8.928